C31H31F5N6O4 — CID 22984013
(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide (PubChem CID 22984013) has the molecular formula C31H31F5N6O4 and a molecular weight of 646.62 g/mol. Its IUPAC name is (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide.
| Compound Name | (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide |
|---|---|
| PubChem CID | 22984013 |
| Molecular Formula | C31H31F5N6O4 |
| Molecular Weight | 646.62 g/mol |
| Exact Mass | 646.23 |
| IUPAC Name | (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide |
| SMILES | CCN(CC)CCN1C(=O)C(NC(=O)[C@H](C)NC(=O)COc2c(F)c(F)c(F)c(F)c2F)N=C(c2ccccn2)c2ccccc21 |
| InChI | InChI=1S/C31H31F5N6O4/c1-4-41(5-2)14-15-42-20-12-7-6-10-18(20)27(19-11-8-9-13-37-19)39-29(31(42)45)40-30(44)17(3)38-21(43)16-46-28-25(35)23(33)22(32)24(34)26(28)36/h6-13,17,29H,4-5,14-16H2,1-3H3,(H,38,43)(H,40,44)/t17-,29?/m0/s1 |
| InChIKey | WXKJQLIPCSXROK-PLKGVSPESA-N |
| XLogP | 3.33 |
| TPSA | 116.23 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 46 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 646.62 |
| LogP ≤ 5 | 3.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'} |
|---|